QC
GILD icon

Quent Capital’s Gilead Sciences GILD Stock Holding History

Quent Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
3,680
+154
+4% +$20.3K 0.03% 248
2026
Q1 		$491K Sell
3,526
-292
-8% -$40.9K 0.03% 209
2025
Q4 		$469K Buy
3,818
+229
+6% +$27.8K 0.03% 229
2025
Q3 		$398K Sell
3,589
-170
-5% -$19.3K 0.03% 173
2025
Q2 		$417K Buy
3,759
+919
+32% +$97.8K 0.04% 169
2025
Q1 		$318K Buy
2,840
+123
+5% +$12.7K 0.03% 188
2024
Q4 		$251K Buy
2,717
+811
+43% +$73K 0.03% 219
2024
Q3 		$160K Buy
1,906
+3
+0.2% +$229 0.02% 390
2024
Q2 		$131K Buy
1,903
+65
+4% +$4.34K 0.01% 401
2024
Q1 		$135K Sell
1,838
-2
-0.1% -$154 0.02% 415
2023
Q4 		$149K Sell
1,840
-220
-11% -$17.1K 0.02% 361
2023
Q3 		$154K Sell
2,060
-165
-7% -$12.7K 0.02% 323
2023
Q2 		$171K Buy
2,225
+87
+4% +$6.94K 0.03% 309
2023
Q1 		$177K Buy
2,138
+471
+28% +$39K 0.03% 304
2022
Q4 		$143K Buy
1,667
+57
+4% +$4.51K 0.03% 330
2022
Q3 		$99K Buy
1,610
+329
+26% +$20.7K 0.02% 377
2022
Q2 		$79K Buy
1,281
+50
+4% +$3.1K 0.02% 402
2022
Q1 		$73K Buy
1,231
+119
+11% +$7.61K 0.01% 494
2021
Q4 		$81K Buy
+1,112
New +$76.6K 0.02% 444

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quent Capital's GILD Position: Q2 2026 in Review

Quent Capital increased its Gilead Sciences (GILD) stake by 4.4% in Q2 2026, buying an estimated $20.3K and bringing the position to 3,680 shares worth $465K. The position accounts for 0.03% of the portfolio, ranked #248.

Quent Capital first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $491K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Quent Capital held 3,680 shares of Gilead Sciences worth $465K as of Q2 2026.
  • Quent Capital bought 154 Gilead Sciences shares in Q2 2026, an estimated $20.3K.
  • Gilead Sciences made up 0.03% of Quent Capital's portfolio in Q2 2026, its #248 holding.
  • Quent Capital first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Quent Capital's Gilead Sciences position peaked at $491K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.